Thinking of joining a study?

Register your interest

NCT03244826 | COMPLETED | Other Cancer


Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation
Sponsor:

Dana-Farber Cancer Institute

Information provided by (Responsible Party):

Gregory A. Abel, MD

Brief Summary:

This research study aims to evaluate the effectiveness of allowing patients who have had a hematopoietic cell transplant to receive some of their post-transplant care with a local oncologist rather than returning to the transplant center for all of their follow-up.

Condition or disease

Other Cancer

Intervention/treatment

Shared Care

Standard Care

Phase

NA

Detailed Description:

Hematopoietic Cell Transplantation (HCT) - also known as bone marrow transplant - is only available at select centers in the United States which can collect and store stem cells, as well as care for patients before their new immune system cells take hold. For this reason, many patients who undergo HCT live at great distances from their HCT center. Also, after hospital discharge, the first 180 days post-HCT are very important, as patients must be managed closely with frequent follow-up visits. A potential way to make life easier for HCT patients is to allow some of the post-transplant care to be provided by local oncologists who practice closer to where patients live. This could reduce the burden on patients and their caregivers; however, it is not known if a shared care model would ultimately benefit them. The investigators want to assess the effectiveness of a Shared Care program which allows patients to receive half of their post-HCT care at the HCT center, and the other half with their local oncologist

Study Type : INTERVENTIONAL
Estimated Enrollment : 404 participants
Masking : NONE
Primary Purpose : HEALTH_SERVICES_RESEARCH
Official Title : Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation
Actual Study Start Date : 2018-01-01
Estimated Primary Completion Date : 2022-08-22
Estimated Study Completion Date : 2022-08-22

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Age \>= 18 years of age
  • * Scheduled to receive an allogeneic HCT at the Dana-Farber Inpatient Hospital or BWH under the care of a DFCI physician
  • * Residence in New York, Maine, New Hampshire, Vermont, Connecticut, or Massachusetts
  • * Referred from or live less than 1 hour from one of the local participating centers.
  • * Ability to read English (to fill out standard QOL forms)
Exclusion Criteria
  • * Age \<18 years of age
  • * Scheduled to receive an autologous HCT
  • * Has received an allogeneic transplant in the past; scheduled to receive a second allogeneic transplant
  • * Did not receive an allogeneic HCT at Dana-Farber
  • * Does not live in New York, Maine, New Hampshire, Vermont, Connecticut, or Massachusetts

Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation

Location Details

NCT03244826


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, Connecticut

Stamford Hospital

Stamford, Connecticut, United States, 06902

Not yet recruiting

United States, Maine

Northern Light Cancer Center dba Eastern Maine Medical Center

Bangor, Maine, United States, 04401

Not yet recruiting

United States, Maine

New England Cancer Specialists

Brunswick, Maine, United States, 04011

Not yet recruiting

United States, Massachusetts

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02215

Not yet recruiting

United States, Massachusetts

Dana-Farber at Milford

Milford, Massachusetts, United States, 01757

Not yet recruiting

United States, Massachusetts

Dana-Farber at South Shore Hospital

Weymouth, Massachusetts, United States, 02190

Not yet recruiting

United States, New Hampshire

Dana-Farber at Londonderry

Londonderry, New Hampshire, United States, 03053

Not yet recruiting

United States, New York

New York Oncology Hematology

Albany, New York, United States, 12206

Not yet recruiting

United States, Rhode Island

Lifespan Cancer Institute at Rhode Island Hospital

Providence, Rhode Island, United States, 02903

Loading...